FC EXA-IV

Ferric Carboxymaltose 500mg/10 ml

Mode of Action

• Intravenous administration of ferric carboxymaltose results in transient elevations in serum iron, serum ferritin and transferrin saturation, and, ultimately, in the correction of haemoglobin levels and replenishment of depleted iron stores.

Dosage

• For patients weighing 50 kg or more, the recommended dosage is FC EXA-IV 750 mg intravenously in two doses separated by at least 7 days for a total cumulative dose of 1,500 mg of iron per course. Alternatively, for patients weighing 50 kg or more, FC EXA-IV 15 mg/kg to a maximum of 1,000 mg may be administered as a single-dose treatment course.
• For patients weighing less than 50 kg, the recommended dosage is FC EXA-IV 15 mg/kg body weight intravenously in two doses separated by at least 7 days per course.
• FC EXA-IV treatment may be repeated if iron deficiency anemia reoccurs.

Indications

• Iron Deficieny Anaemia.
• Heavy Uterine Bleeding.
• Pre & Postoperative Anemia.
• Postpartum Iron – deficieny Anaemia.